Home/Filings/4/0001562180-25-000187
4//SEC Filing

Chan Mitchell 4

Accession 0001562180-25-000187

CIK 0001590877other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:59 PM ET

Size

9.2 KB

Accession

0001562180-25-000187

Insider Transaction Report

Form 4
Period: 2025-01-02
Chan Mitchell
Chief Financial Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2025-01-02+62,54762,547 total
    Exercise: $7.86Exp: 2035-01-02Common Stock (62,547 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001789335

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:59 PM ET
Size
9.2 KB